PLRZ Key Statistics, Chart & Performance
The current stock price of PLRZ is 12.79 USD. In the past month the price increased by 14.91%. In the past year, price decreased by -99.42%.
PLRZ Latest News, Press Relases and Analysis
PLRZ Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 23.29 | 388.96B | ||
| AMGN | AMGEN INC | 14.91 | 175.60B | ||
| GILD | GILEAD SCIENCES INC | 14.79 | 150.25B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 26.72 | 117.69B | ||
| REGN | REGENERON PHARMACEUTICALS | 17.7 | 83.72B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 780.96 | 52.62B | ||
| INSM | INSMED INC | N/A | 37.53B | ||
| NTRA | NATERA INC | N/A | 32.34B | ||
| BIIB | BIOGEN INC | 11.21 | 27.52B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 22.94B | ||
| INCY | INCYTE CORP | 16.65 | 20.98B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.31 | 20.81B |
Related stock screener links
About PLRZ
Company Profile
Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. The firm is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The firm is focused not only on the development of intranasal products, but also on commercialization. The firm cooperates with medical specialists and researchers..
Company Info
POLYRIZON LTD
HaTidhar St. 5
Ra'anana IL
Employees: 1
Phone: 97293740120
POLYRIZON LTD / PLRZ FAQ
Can you describe the business of POLYRIZON LTD?
Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. The firm is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The firm is focused not only on the development of intranasal products, but also on commercialization. The firm cooperates with medical specialists and researchers..
What is the current price of PLRZ stock?
The current stock price of PLRZ is 12.79 USD. The price decreased by -4.62% in the last trading session.
What is the dividend status of POLYRIZON LTD?
PLRZ does not pay a dividend.
How is the ChartMill rating for POLYRIZON LTD?
PLRZ has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Can you provide the PE ratio for PLRZ stock?
POLYRIZON LTD (PLRZ) does not have a PE ratio as the earnings reported over the last twelve months were negative (-807.27).
What is the ownership structure of POLYRIZON LTD (PLRZ)?
You can find the ownership structure of POLYRIZON LTD (PLRZ) on the Ownership tab.
PLRZ Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to PLRZ. When comparing the yearly performance of all stocks, PLRZ is a bad performer in the overall market: 75.51% of all stocks are doing better.
PLRZ Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to PLRZ. While PLRZ has a great health rating, there are worries on its profitability.
PLRZ Financial Highlights
Over the last trailing twelve months PLRZ reported a non-GAAP Earnings per Share(EPS) of -807.27. The EPS decreased by -207.27% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -9.51% | ||
| ROE | -9.7% | ||
| Debt/Equity | 0 |